Clinical Trial Update: Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 open-label trial sponsored by CorMedix to assess safety and time to catheter-related bloodstream infections in pediatric patients from birth to under 18…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Snippet

Sponsor: CorMedix | Conditions: Catheter-Related Infections | Phase 4 | Status: RECRUITING